Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
AD     Remove this Ad

TORRENT PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 8.1124.0847.24-21.1914.78

What is the latest EBIT Growth ratio of TORRENT PHARMACEUTICALS ?

The latest EBIT Growth ratio of TORRENT PHARMACEUTICALS is 8.11 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar20258.11
Mar202424.08
Mar202347.24
Mar2022-21.19
Mar202114.78

How is EBIT Growth of TORRENT PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 8.11
-66.32
Mar2024 24.08
-49.03
Mar2023 47.24
Positive
Mar2022 -21.19
Negative
Mar2021 14.78 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EBIT Growth ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹144,375.0 Cr 2.1% -0.4% 31.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,837.0 Cr 2.9% 3.6% 0.2% Stock Analytics
DIVIS LABORATORIES ₹159,175.0 Cr 0.6% -4.5% 3.4% Stock Analytics
DR REDDYS LABORATORIES ₹106,999.0 Cr 2.2% -0.4% 6.2% Stock Analytics
CIPLA ₹100,379.0 Cr 0.4% -6.2% -19.4% Stock Analytics
MANKIND PHARMA ₹84,227.3 Cr 1% -1.3% -11.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

2.1%

-0.4%

31.8%

SENSEX

-0.8%

-11.7%

-3.6%


You may also like the below Video Courses